Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Upadacitinib effectively treats psoriasis and lichen planus together.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Dupilumab may help regrow hair in people with atopic dermatitis.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Baricitinib works better than methotrexate for severe alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

A patient with a rare hair condition and skin disorder showed hair improvement after treatment.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Betulinic acid can help treat hepatitis C by stopping virus replication.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

A woman had eye pain and vision loss after a hair growth treatment, but her symptoms improved after a month.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.